Termine
Präsentationen
Aktie
Aktueller Finanzbericht
News
Neueste
Tweets
vor 2 Tage 18 Stunden
@MorphoSys
@MorphoSys is looking forward to be at #ASH2019 in Orlando – come and visit us at booth #1261
View our abstracts ac… https://t.co/8frQalvXlh
vor 2 Wochen 3 Tage
@MorphoSys
@MorphoSys today announced that tafasitamab B-MIND DLBCL study successfully passed interim analysis… https://t.co/GKEruipifQ
vor 1 Monat 2 Wochen
@MorphoSys
@MorphoSys today takes part at #LightTheNight in Boston organized by @LLSusa to help fund treatments that are savin… https://t.co/kdwPTbD1F0
vor 1 Monat 3 Wochen
@MorphoSys
“Thank you @JohnCendpts for moderating this great panel on ‘Cancer Drug Trials’ and for having me as speaker. It wa… https://t.co/yZU8hgcDUa
vor 2 Monate 2 Tage
@MorphoSys
To maximise the value of our key asset #tafasitamab (MOR208) “We’ll do what makes sense for the patients and for ou… https://t.co/78POIo1yR5
vor 2 Monate 1 Woche
@MorphoSys
Thank you #Berenberg & @GoldmanSachs. It was a great 8th German Corporate #Conference in #Munich.
Our new CEO Jean-… https://t.co/89oAuX5KuN
vor 2 Monate 2 Wochen
@MorphoSys
#MorphoSys announced that the licensee @JanssenGlobal reported submission of a supplemental Biologics License Appl… https://t.co/zZTaX0tmGb
vor 2 Monate 3 Wochen
@MorphoSys
#WorldLymphomaDay Thank you to the doctors, nurses, scientists, researchers and people who dedicate their lives to… https://t.co/gCmsQrZffP
vor 2 Monate 3 Wochen
@MorphoSys
vor 2 Monate 3 Wochen
@MorphoSys
MorphoSys neuer CEO Jean-Paul Kress im Interview mit Börse Online: “Das Spannende an der neuen Position ist, das Un… https://t.co/LvNNROegoU
Medien und Investoren
Dr. Sarah Fakih
Vice President/Head of Corporate Communications & Investor Relations
Telefon +49 89 89927 26663
Dr. Julia Neugebauer
Director Corporate Communications & Investor Relations
Telefon +49 89 89927 179
Dr.Verena Kupas
Manager Corporate Communications & Investor Relations
Telefon +49 89 89927 26814
Alexandra Goller
Director Corporate Communications & Investor Relations
Telefon +49 89 89927 332
Nicola Thomas
Specialist Corporate Communications & Investor Relations - Koordination & Administration
Telefon +49 89 89927 249